Anika Therapeutics - 30 Year Stock Price History | ANIK
Historical daily share price chart and data for Anika Therapeutics since 1993 adjusted for splits. The latest closing stock price for Anika Therapeutics as of June 02, 2023 is 27.27.
- The all-time high Anika Therapeutics stock closing price was 73.36 on October 25, 2019.
- The Anika Therapeutics 52-week high stock price is 32.51, which is 19.2% above the current share price.
- The Anika Therapeutics 52-week low stock price is 20.12, which is 26.2% below the current share price.
- The average Anika Therapeutics stock price for the last 52 weeks is 26.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Anika Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2023 |
28.5381 |
29.4800 |
32.1000 |
25.1600 |
27.2700 |
-7.87% |
| 2022 |
26.0488 |
36.5400 |
36.5400 |
20.4000 |
29.6000 |
-17.39% |
| 2021 |
40.4562 |
42.8400 |
48.0800 |
32.4900 |
35.8300 |
-20.84% |
| 2020 |
36.8543 |
52.4000 |
54.0600 |
22.3800 |
45.2600 |
-12.71% |
| 2019 |
45.1985 |
34.5200 |
73.3600 |
29.3700 |
51.8500 |
54.27% |
| 2018 |
43.2097 |
54.9100 |
68.4300 |
28.7700 |
33.6100 |
-37.66% |
| 2017 |
50.3632 |
50.1100 |
59.9400 |
41.7200 |
53.9100 |
10.11% |
| 2016 |
45.8884 |
38.0800 |
54.2600 |
35.3000 |
48.9600 |
28.30% |
| 2015 |
37.2732 |
39.7600 |
45.2100 |
31.3500 |
38.1600 |
-6.33% |
| 2014 |
41.0168 |
34.9900 |
50.4300 |
29.4800 |
40.7400 |
6.76% |
| 2013 |
20.0087 |
10.8700 |
38.1600 |
10.2200 |
38.1600 |
283.90% |
| 2012 |
12.7090 |
9.3100 |
17.5400 |
9.0800 |
9.9400 |
1.43% |
| 2011 |
7.5280 |
6.7300 |
11.1700 |
5.3300 |
9.8000 |
46.93% |
| 2010 |
6.2777 |
7.5600 |
7.9000 |
4.9500 |
6.6700 |
-12.58% |
| 2009 |
5.6700 |
3.1200 |
9.0500 |
3.0500 |
7.6300 |
150.99% |
| 2008 |
8.3621 |
15.1800 |
15.1800 |
3.0000 |
3.0400 |
-79.11% |
| 2007 |
15.4437 |
13.1700 |
21.8000 |
12.3100 |
14.5500 |
9.65% |
| 2006 |
11.9701 |
11.5400 |
14.7400 |
9.5000 |
13.2700 |
13.52% |
| 2005 |
12.1348 |
9.0000 |
17.0000 |
8.1000 |
11.6900 |
27.76% |
| 2004 |
11.4183 |
9.3600 |
17.5300 |
6.8000 |
9.1500 |
-6.06% |
| 2003 |
4.1682 |
1.0400 |
11.5000 |
0.9900 |
9.7400 |
883.84% |
| 2002 |
1.1214 |
1.1000 |
1.3900 |
0.8500 |
0.9900 |
-1.00% |
| 2001 |
1.1379 |
0.8125 |
1.6880 |
0.8125 |
1.0000 |
27.99% |
| 2000 |
4.2242 |
7.0000 |
11.5000 |
0.7500 |
0.7813 |
-88.94% |
| 1999 |
5.9460 |
5.0630 |
8.6880 |
4.5000 |
7.0630 |
31.40% |
| 1998 |
10.2554 |
8.6250 |
18.1900 |
3.9380 |
5.3750 |
-42.28% |
| 1997 |
6.7512 |
3.8750 |
10.5000 |
3.8750 |
9.3130 |
148.35% |
| 1996 |
4.7312 |
3.8800 |
7.5000 |
3.4400 |
3.7500 |
-3.23% |
| 1995 |
2.5569 |
1.8750 |
3.8750 |
1.6200 |
3.8750 |
106.67% |
| 1994 |
2.7154 |
4.0310 |
4.1250 |
1.5000 |
1.8750 |
-58.04% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.402B |
$0.156B |
|
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
|
